Healthcare -
Biotechnology - NASDAQ - US
$ 246.27
-1.16 %
$ 31.8 B
Market Cap
-94.0
P/E
ALNY - TOTAL RECEIVABLES
Total Receivables ALNY - Alnylam Pharmaceuticals, Inc.
328 M
LAST VALUE
28.48%
2 YEAR CAGR
77.20%
5 YEAR CAGR
54.43%
10 YEAR CAGR